secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001437749-26-013638
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
LLM model:  deepseek-v4-flash:cloud@v2

Filana Therapeutics board member Michael O'Donnell resigns effective at 2026 annual meeting
--------------------------------------------------------------------------------

- Michael O'Donnell notified Filana's Board of his resignation on April 22, 2026.
- Resignation is effective at the conclusion of the 2026 annual meeting of stockholders.
- O'Donnell will continue to serve as a director until the effective date.
- Resignation was not due to any disagreement with Company, management, or Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774926013638/0001437749-26-013638-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774926013638/sava20260427_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-013638

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer